Skip to main content

Share Article

Urenco’s commitment to the Treaty of Almelo

14 June 2017 Global News

Urenco is a leading international provider of uranium enrichment services. The company is embedded in a system of international legal agreements that ensure the peaceful use of nuclear energy worldwide. Urenco USA enriches uranium for civil power generation under the terms of the Treaty of Washington. This is in full compliance with the terms and principles of the Treaty of Almelo which ensures the peaceful application of nuclear power.

Furthermore, international agreements ensure we consistently meet the stringent inspection criteria set by IAEA and EURATOM. These extensive control mechanisms act as a model for nuclear non-proliferation.

Share Article

Line

More global stories

‘No time to lose’, nuclear conference told

Global 23 April 2025

Urenco attends the Canadian Nuclear Association 2025 in Ottawa.

Read more ‘No time to lose’, nuclear conference told

Urenco attends the Canadian Nuclear Association 2025 in Ottawa.

Read more ‘No time to lose’, nuclear conference told

Urenco shares a stage at the World Nuclear Fuel Cycle 2025.

Read more Project delivery key to nuclear’s future, conference hears

About Urenco

Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.

With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.

Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.

Media enquiries

T: +44 (0)1753 660 705
E: [email protected]

Back to
the goals